glp-1 with least side effects medications have changed the conversation around weight management, but they're not without effects. The most common concerns include nausea, constipation, fatigue, muscle loss and nutritional inadequacies—many of which can be Non-Diabetic Patients on GLP-1 Medications

Information on state Medicaid coverage of GLP-1s for obesity comes from a January 2026 report from KFF, a nonpartisan research organization focused on health policy

Wegovy 0.5mg was out of stock in 4 of the last 8 weeks

These 3.8 million met the clinical criteria for the Bridge program, did not have a diagnosis of type 2 diabetes, sleep apnea or MASH, did not have a GLP-1 Part D covered prescription in 2023 and "could be eligible for the Medicare GLP-1 Bridge, assuming no changes in diagnosis or GLP-1 use in Part D in 2026," the report added

Recent studies among obese individuals without diabetes found poor 1-year persistence and adherence

"While providers and plan sponsors emphasize the need for structured requirements to ensure effective use of GLP-1 therapies, pharmacists play a critical role in implementing these measures by supporting patients with education, safe use and adherence strategies," the study said.

This marks Teva's fifth first-to-market entry for a generic product this year, according to SVP and head of US commercial generics Ernie Richardsen